4.4 Review

The global impact of IBS: time to think about IBS-specific models of care?

期刊

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1756283X17718677

关键词

burden; IBS; model of care

资金

  1. Almirall Pharma
  2. Boehringer-Ingelheim
  3. Chr. Hansen
  4. Danone Research
  5. Ironwood Pharmaceuticals
  6. Salix
  7. Shire UK
  8. Sucampo Pharmaceuticals
  9. Allergan

向作者/读者索取更多资源

Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal (GI) disorder that can significantly erode the quality of life (QoL) of sufferers and places a major cost burden on healthcare services. This paper reviews the literature on the impact of IBS on healthcare services and society, including a recent report on the subject, in order to formulate a plan for the future. A completely different model of care for these patients is recommended based on this review and the experience of the two authors who have been treating patients with functional GI disorders for 20 and 35 years, respectively.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据